Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Buy
73
OSCR Quote, Financials, Valuation and Earnings
Last price:
$17.74
Seasonality move
:
53.74%
Day range:
$17.39 - $18.20
52-week range:
$11.20 - $23.80
Dividend yield:
0%
P/E ratio:
51.21x
P/S ratio:
0.42x
P/B ratio:
4.99x
Volume:
11.2M
Avg. volume:
8.4M
1-year change:
15.96%
Market cap:
$5.1B
Revenue:
$9.2B
EPS (TTM):
-$1.12
Analysts' Opinion
-
Consensus RatingOscar Health, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 6 Hold ratings, and 2 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $15.78, Oscar Health, Inc. has an estimated downside of -11.01% from its current price of $17.73.
-
Price Target UpsideAccording to analysts, the highest upside price target is $25.00 representing 41% upside increase from its current price of $17.73.
Fair Value
-
According to the consensus of 8 analysts, Oscar Health, Inc. has -11.01% downside to fair value with a price target of $15.78 per share.
OSCR vs. S&P 500
-
Over the past 5 trading days, Oscar Health, Inc. has overperformed the S&P 500 by 16.6% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Oscar Health, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Oscar Health, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Oscar Health, Inc. reported revenues of $3B.
Earnings Growth
-
Oscar Health, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Oscar Health, Inc. reported earnings per share of -$0.53.
Enterprise value:
5.8B
EV / Invested capital:
--
Price / LTM sales:
0.42x
EV / EBIT:
5.79x
EV / Revenue:
0.51x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
7.88x
Price / Operating cash flow:
6.44x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-4.65%
Net Income Margin (TTM):
-2.16%
Return On Equity:
-21.36%
Return On Invested Capital:
-16.06%
Operating Margin:
-4.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $5.4B | $8.2B | $11.3B | $2.4B | $3B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$312.6M | $59.5M | -$210.3M | -$48.4M | -$129.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -$1.60 | -$0.06 | -$1.12 | -$0.22 | -$0.53 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.8B | $3.1B | $2.7B | $2.1B | $3.6B | |
| Total Assets | $2.8B | $3.5B | $3.1B | $4.2B | $5.6B | |
| Current Liabilities | $1.2B | $2B | $1.8B | $2.7B | $3.8B | |
| Total Liabilities | $1.2B | $2.4B | $2.2B | $3B | $4.6B | |
| Total Equity | $1.6B | $1.1B | $921.4M | $1.2B | $1B | |
| Total Debt | -- | $297.8M | $298.6M | $299.4M | $686.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$417.6M | $928.2M | $769.8M | -$500.1M | -$964.7M | |
| Cash From Investing | -$302M | -$1.2B | -$223.8M | -$577.8M | $150.1M | |
| Cash From Financing | $5.9M | $65.6M | $394.9M | $18.6M | $364M | |
| Free Cash Flow | -$444.2M | $901.1M | $735.6M | -$507.7M | -$973.7M | |
OSCR
Sector
Market Cap
$5.1B
$545.1M
Price % of 52-Week High
74.5%
91.94%
Dividend Yield
0%
1.53%
Shareholder Yield
-2.49%
3.06%
1-Year Price Total Return
15.96%
9.22%
Beta (5-Year)
--
0.456
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$15.95
200-day SMA
Buy
Level
$16.18
Bollinger Bands (100)
Buy
Level
15.34 - 19.64
Chaikin Money Flow
Sell
Level
-274.3M
20-day SMA
Buy
Level
$15.62
Relative Strength Index (RSI14)
Buy
Level
64.87
ADX Line
Buy
Level
17.4
Williams %R
Sell
Level
-11.6625
50-day SMA
Buy
Level
$16.05
MACD (12, 26)
Buy
Level
0.12
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Sell
Level
-96.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.573)
Sell
CA Score
(Annual)
Level (-0.755)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-3.9658)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.
Stock Forecast FAQ
In the current month, OSCR has received 0 Buy ratings 6 Hold ratings, and 2 Sell ratings. The OSCR average analyst price target in the past 3 months is $15.78.
-
Where Will Oscar Health, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Oscar Health, Inc. share price will drop to $15.78 per share over the next 12 months.
-
What Do Analysts Say About Oscar Health, Inc.?
Analysts are divided on their view about Oscar Health, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that Oscar Health, Inc. is a Buy and believe this share price will rise from its current level to $25.00.
-
What Is Oscar Health, Inc.'s Price Target?
The price target for Oscar Health, Inc. over the next 1-year time period is forecast to be $15.78 according to 8 Wall Street analysts, 0 of them rate the stock a Buy, 2 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is OSCR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Oscar Health, Inc. is a Hold. 6 of 8 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of OSCR?
You can purchase shares of Oscar Health, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Oscar Health, Inc. shares.
-
What Is The Oscar Health, Inc. Share Price Today?
Oscar Health, Inc. was last trading at $17.74 per share. This represents the most recent stock quote for Oscar Health, Inc.. Yesterday, Oscar Health, Inc. closed at $17.73 per share.
-
How To Buy Oscar Health, Inc. Stock Online?
In order to purchase Oscar Health, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get OSCR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
OSCR
Sector
P/E ratio
51.21x
12.27x
PEG ratio
-0.01x
0.31x
P/B ratio
4.99x
1.11x
Price / LTM sales
0.42x
1.82x
Growth Metrics
OSCR
Sector
Revenue growth
23.21%
5.48%
Earnings growth
-136.02%
14.6%
Revenue (5-year growth)
79.82%
8.8%
Earnings forecast
-$0.92
$0.64
Profitability
OSCR
Sector
Profitability FY 2024
--
--
Return on invested capital
-16.06%
5%
Return on assets
-4.65%
1%
Return on equity
-21.36%
9.65%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
3
Estimated Next Earnings Date
Feb
5
Balance Sheet
OSCR
Sector
Total cash
$3.5B
$420.3M
Short term investments
$624.5M
$198.2M
Total assets
$4.5B
$3B
Long term debt
$686.3M
$77M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
65
RGC alert for Jan 10
Regencell Bioscience Holdings Ltd. [RGC] is up 10.55% over the past day.
Sell
50
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
